Robust Immune Response Induced by Schistosoma mansoni TSP-2 Antigen Coupled to Bacterial Outer Membrane Vesicles
Mayra M F Barbosa,1,2 Alex I Kanno,1 Giovana C Barazzone,1 Dunia Rodriguez,1 Violeta Pancakova,1,3 Monalisa Trentini,1 Eliana L Faquim-Mauro,4 Amanda P Freitas,4 Mariana I Khouri,5 Jessica Lobo-Silva,5 Viviane M Goncalves,1 Rocilda P F Schenkman,1 Martha M Tanizaki,1 Diana Boraschi,6– 8 Richard Mall...
Guardado en:
Autores principales: | Barbosa MMF, Kanno AI, Barazzone GC, Rodriguez D, Pancakova V, Trentini M, Faquim-Mauro EL, Freitas AP, Khouri MI, Lobo-Silva J, Goncalves VM, Schenkman RPF, Tanizaki MM, Boraschi D, Malley R, Farias LP, Leite LCC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e812b9869d0f45eb83004fb272c78a25 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice
por: Dkhi,Mohamed A
Publicado: (2014) -
QUETOTAXIA CERCARIANA DE LA CEPA CARABALLEDA DE Schistosoma mansoni
por: PINO,LUZ A., et al.
Publicado: (1998) -
Design, synthesis, and evaluation of VEGFR-targeted macromolecular MRI contrast agent based on biotin–avidin-specific binding
por: Liu YJ, et al.
Publicado: (2017) -
Prevalence of Schistosoma mansoni infection among children in Ethiopia: a systematic review and meta-analysis
por: Habtye Bisetegn, et al.
Publicado: (2021) -
Praziquantel–lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting
por: Amara RO, et al.
Publicado: (2018)